Evidence describing the immunomodulating effects of LDN [96] and its impact on the synthesis and modulation of signaling pathways associated with IL-2 [19] supports the hypothesis that IL-2+LDN immunotherapy may provide therapeutic benefits in cancers showing increased expression of OGF and OGFr [96]. This evidence concerns the gene OGFR and cancer.